501 filings
Page 2 of 26
8-K
m46g8jh073r4func
6 May 20
Announcement relating to the outcome of the Court Sanction Hearing
7:17am
8-K
68st pcp8nh171ul3q1
21 Apr 20
Temporary Suspension of Trading Under Registrant's Employee Benefit Plans
4:16pm
8-K
d6m0kky3zwspnq8vxu4c
18 Mar 20
AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction
12:00am
8-K
mwcv8qsqjrjuy
3 Mar 20
AbbVie and Allergan Receive Final European Approval to Close Pending Transaction
4:05pm
8-K
4pknt84brstb aawsyu
10 Feb 20
Allergan Reports Fourth Quarter and Full-Year 2019 Financial Results
7:25am
8-K
snk38l3wgbsh9kyz6b
27 Jan 20
AbbVie and Allergan Announce Agreements to Divest Brazikumab and Zenpep
8:00am
8-K
ynf2mt 75e91
5 Nov 19
Third Quarter 2019 Financial Results—Frequently Asked Questions
8:11am
8-K
2d9c9kgfzui5b
5 Nov 19
Allergan Reports Third Quarter 2019 Financial Results
7:17am
8-K
psm8k
15 Oct 19
Allergan Shareholders Approve Proposed Acquisition by AbbVie
6:30am
DEFA14A
h2b6 tbdbp8950wvvutr
3 Oct 19
Additional proxy soliciting materials
4:10pm
DEFA14A
wrlv7iq3 bctjbz
27 Sep 19
Additional proxy soliciting materials
4:50pm
8-K
884 0v3iwl
27 Sep 19
Other Events
4:45pm
8-K
39fiychbmd ozrkii
16 Sep 19
Report of Pricewaterhousecoopers Ireland on Allergan Profit
4:16pm
DEFA14A
gjwy mkif2op
11 Sep 19
Additional proxy soliciting materials
12:00am
8-K
0fbe7nqvy bre
11 Sep 19
Other Events
12:00am